NEOG

Neogen Corporation
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$2.59B
P/E Ratio
EPS
$-0.04
Beta
1.77
52W High
$12.85
52W Low
$4.90
50-Day MA
$9.94
200-Day MA
$8.95
Dividend Yield
Profit Margin
-0.91%
Forward P/E
16.00
PEG Ratio
0.66

About Neogen Corporation

Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.

Official WebsiteUSAFY End: May

Fundamentals

Revenue (TTM)$870.40M
Gross Profit (TTM)$408.50M
EBITDA$94.70M
Operating Margin1.38%
Return on Equity-0.38%
Return on Assets-0.40%
Revenue/Share (TTM)$4.00
Book Value$9.61
Price-to-Book1.21
Price-to-Sales (TTM)2.97
EV/Revenue3.615
EV/EBITDA18.45
Quarterly Earnings Growth (YoY)-85.60%
Quarterly Revenue Growth (YoY)-0.10%
Shares Outstanding$218.06M
Float$216.77M
% Insiders0.95%
% Institutions111.24%

Historical Volatility

HV 10-Day
32.77%
HV 20-Day
79.86%
HV 30-Day
68.49%
HV 60-Day
55.87%
HV Rank
73.8%

Volatility is currently contracting

Analyst Ratings

Consensus ($13.00 target)
1
Strong Buy
1
Buy
2
Hold

Latest News

PRGO vs. NEOG: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research8/10/2026Positive
Neogen (NEOG) Beats Q4 Earnings and Revenue Estimates

Neogen (NEOG) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.

Zacks Investment Research7/30/2026Positive
Neogen Q4 Earnings Call Highlights

Neogen NASDAQ: NEOG reported fiscal fourth-quarter revenue of $225.3 million, with core revenue growth of 4.3%, its highest growth rate of fiscal 2026. The company said momentum improved across both its food safety and animal safety businesses as it entered fiscal 2027, while management outlined increased spending on research and development, commercial capabilities and technology.

MarketBeat7/30/2026Positive
Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal fourth quarter and full fiscal year 2026 and provided financial guidance for its fiscal year first quarter and full fiscal year 2027. “We ended fiscal year 2026 with significant momentum and have a number of initiatives underway to further enhance our commercial efforts and the way we approach customers and our core markets. Fiscal ye.

Business Wire7/30/2026Neutral
Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 2026

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening of the market on Thursday, July 30, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company's performance for the fourth-quarter of fiscal year 2026. The conference call can be accessed.

Business Wire7/20/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NEOG and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026